MNI China Daily Summary: Friday, April 26

MNI BRIEF: China, US Should Strengthen Dialogue, Cooperation

MNI BRIEF: SNB Framework Reform 'Playing With Fire' - Steiner

MNI: PBOC Conducts CNY2 Bln Via OMO Fri; Liquidity Unchanged

CHINA PBOC INJECTS CNY2 BILLION VIA 7-DAY REVERSE REPOS FRI

MNI: PBOC Sets Yuan Parity Lower At 7.1056 Fri; -4.56% Y/Y

MNI: BAKER HUGHES US RIG COUNT 613; OIL RIGS 506; GAS RIGS 105

MNI: UNIV OF MICHIGAN CONSUMER SENTIMENT FINAL APR INDEX 77.2

EZ/UK T-Bill Calendar: Germany, France Auction on Monday

RPT-MNI: Canada Sticks To Fiscal Anchors, Spends Chunk Of Windfall

MNI BRIEF: Poilievre Calls QE 'Scam' And Would Limit BOC Remit

MNI: Growth Drag From Net Zero Carbon Goal Can Be Offset-OECD

© 1982-2023 MNI. All rights reserved.
Terms | Privacy
Log Out
Free Trial

Walgreens Boots (WBA; Ba2 Stable, BBB- Neg) {WBA US Equity} 2Q (3-months ending Feb)

CONSUMER STAPLES
Credit BulletsHomepagemarkets-real-timeCreditBullet
  • On Headline; A revenue beat of $1b+ at $37.1b, adj. gross margin ~in line at 19.1% (c19.14%), adj. operating margin at 2.4% (c2.1%). Improved profitability in US healthcare & favourable tax rates helped adj. EPS beat at $1.2 (c$0.82). Stock is up +2.8% in pre-market, note all adjusted (it had a $12.4b (non-cash) impairment of charge on VilageMD goodwill).
  • In US; Pharamacy comparable sales increased 8.7%yoy helped by "higher branded drug inflation", US comparable retail sales fell -4.3% reflecting "a challenging retail environment, channel shift & weaker respiratory season (-0.9% impact from softer cold/flue trends)".
  • In Europe: International sales rose +3.2% (cc) with Germany wholesale +5.3% & Books UK +3%. Boots pharmacy was +1.7%, retail +5.9% - its attributing latter in part to increasing market share. Boots.com now makes up 17% of total retail with growth of +16.8%yoy.
  • On BS; FCF over the qtr was negative $610m, impacted by -$615m in legal payments and -$379m Boots pension plan annuity premiums. $668m cash on hand, debt (including leases) were slightly up. Debt paydowns (net of issuance) is ~0 over last 6 months.
  • On Guidance: cutting FY24 guidance to EPS of $3.2-3.35 "reflecting challenging retail environment in the U.S., early wind-down of sale-leaseback program, and lower earnings due to Cencora share sales". Maintains US helathcare adj. EBITDA to be breakeven/midpoint of guidance (-$50 to +$50m)

WBA singe €26's (Z+112) & £25's (Z+138) little changed. Earnings call is at 12:30pm Lon/8:30am ET; https://edge.media-server.com/mmc/p/78tosw8j/

240 words

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.
  • On Headline; A revenue beat of $1b+ at $37.1b, adj. gross margin ~in line at 19.1% (c19.14%), adj. operating margin at 2.4% (c2.1%). Improved profitability in US healthcare & favourable tax rates helped adj. EPS beat at $1.2 (c$0.82). Stock is up +2.8% in pre-market, note all adjusted (it had a $12.4b (non-cash) impairment of charge on VilageMD goodwill).
  • In US; Pharamacy comparable sales increased 8.7%yoy helped by "higher branded drug inflation", US comparable retail sales fell -4.3% reflecting "a challenging retail environment, channel shift & weaker respiratory season (-0.9% impact from softer cold/flue trends)".
  • In Europe: International sales rose +3.2% (cc) with Germany wholesale +5.3% & Books UK +3%. Boots pharmacy was +1.7%, retail +5.9% - its attributing latter in part to increasing market share. Boots.com now makes up 17% of total retail with growth of +16.8%yoy.
  • On BS; FCF over the qtr was negative $610m, impacted by -$615m in legal payments and -$379m Boots pension plan annuity premiums. $668m cash on hand, debt (including leases) were slightly up. Debt paydowns (net of issuance) is ~0 over last 6 months.
  • On Guidance: cutting FY24 guidance to EPS of $3.2-3.35 "reflecting challenging retail environment in the U.S., early wind-down of sale-leaseback program, and lower earnings due to Cencora share sales". Maintains US helathcare adj. EBITDA to be breakeven/midpoint of guidance (-$50 to +$50m)

WBA singe €26's (Z+112) & £25's (Z+138) little changed. Earnings call is at 12:30pm Lon/8:30am ET; https://edge.media-server.com/mmc/p/78tosw8j/